
Pangenome Reveals Hidden Melanoma Mutations
Washington University researchers found thousands of cancer-linked mutations missed by the conventional human reference genome.
Coverage of diseases in St. Louis focuses on diagnosis, treatment breakthroughs and public health impact. Reporting follows the latest findings in research alongside local response to health alerts.

Washington University researchers found thousands of cancer-linked mutations missed by the conventional human reference genome.
A study at Washington University School of Medicine tracks how tumors evolve during standard chemoradiation therapy.
Live Poll
Should medical institutions make large-scale research datasets more accessible to the public?
The new Knight Alzheimer Research Imaging dataset provides thousands of brain scans to help study Alzheimer’s disease progression.

Live Poll
Do you plan to get a flu shot for yourself or your family this season?
The network launched four locations to provide convenient vaccinations for residents.

Live Poll
Do recent discoveries in genetic pathways increase your trust in the future of medical treatments?
A new study reveals how UBE3A gene loss triggers a biological stress response that disrupts protein synthesis in the brain.

Live Poll
Should insurance companies simplify their approval processes for preventative medical treatments?
A recent study found that insurance issues prevented over 40 percent of patients at a St. Louis clinic from receiving treatment.

Day to day, that means monitoring clinical trials, awareness campaigns, treatment advancements and updates on current outbreaks. Coverage reaches across the city and the communities around it. Seasonal patterns often dictate the flow of information for respiratory conditions, while emerging science dictates the pace for chronic illness management. Public health responses and the availability of clinical data are the variables that shape this reporting most often.